Krebs Biochemicals & Industries Ltd
Krebs Biochemicals & Industries Ltd Share Price Today: Live Updates & Key Insights
Get insights on Krebs Biochemicals & Industries Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Krebs Biochemicals & Industries Ltd Share Price Chart
KREBSBIO at 09 Feb 2026 09:48 AM Pharmaceuticals
57.00 -2.08(-3.52%)
Lowest Today 51.00
Highest Today 59.92
Today's Open 58.00
Prev. Close 59.08
52 Week High 113.90
52 Week Low 51.00
Krebs Biochemicals & Industries Ltd Fundamentals
Traded Volume: 3,659
Market Cap(Cr): 123
Avg Traded Price 56.40
1 Year return -43.00%
Upper Circuit 59.9
Lower Circuit 51
P/E TTM -5.00
P/B Ratio -0.846
Traded Value(Cr) 2.09
EPS TTM -12.743
Book value/Share -67.830
Dividend Yield 1Y 0.00%
Krebs Biochemicals & Industries Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Krebs Biochemicals & Industries Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Krebs Biochemicals & Industries Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -5.65%
1M -17.47%
3M -15.72%
1Y -43.00%
YTD -15.95%
Krebs Biochemicals & Industries Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Krebs Biochemicals & Industries Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 2329.00
Day Before Yesterday 11713.00
1W Avg 6346.20
1M Avg 5484.30
3M Avg 11052.02
Krebs Biochemicals & Industries Ltd Technical Details
Krebs Biochemicals & Industries Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 54
Support 2 51
Support 3 49
Pivot Point : 57
Resistance 1 60
Resistance 2 63
Resistance 3 66
Krebs Biochemicals & Industries Ltd Corporate Actions
Krebs Biochemicals & Industries Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Krebs Biochemicals & Industries Ltd’s capital allocation strategies.
All
Ex-Date 31-Jan-2019 Type R Description /share@21:100% Record Date 01-Feb-2019 Ratio 21:100
Dividends
No Dividend has been declared by KREBSBIO
Bonus
No Bonus has been declared by KREBSBIO
Splits
No Split has been declared by KREBSBIO
Others
Ex-Rights Date 31-Jan-2019 Premium(Rs.) 76.00 Ratio 21:100
Krebs Biochemicals & Industries Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Krebs Biochemicals & Industries Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Krebs Biochemicals & Industries Ltd's relative performance and valuation against major competitors.
Stock Name Accretion Nutraveda Ltd ₹175.00 (-0.96%) M. Cap (Cr) 1.27 1 Yr Return (%) NaN% P/E (TTM) 48.49 PB Ratio 12.44
Stock Name Lactose (India) Ltd ₹98.18 (-3.29%) M. Cap (Cr) 1.24 1 Yr Return (%) -47.07% P/E (TTM) 27.36 PB Ratio 1.98
Stock Name Balaxi Pharmaceuticals Ltd ₹23.39 (+2.27%) M. Cap (Cr) 1.29 1 Yr Return (%) -66.48% P/E (TTM) 13.68 PB Ratio 0.54
Stock Name Krebs Biochemicals & Industries Ltd ₹57.41 (-2.31%) M. Cap (Cr) 1.24 1 Yr Return (%) -42.59% P/E (TTM) -4.51 PB Ratio -0.78
Stock Name Tyche Industries Ltd ₹112.90 (+0.80%) M. Cap (Cr) 1.16 1 Yr Return (%) -27.28% P/E (TTM) 11.90 PB Ratio 0.82
Stock Name Par Drugs & Chemicals Ltd ₹99.12 (+8.07%) M. Cap (Cr) 1.22 1 Yr Return (%) -47.83% P/E (TTM) 12.59 PB Ratio 1.15
Stock Name Bal Pharma Ltd ₹69.10 (-1.19%) M. Cap (Cr) 1.10 1 Yr Return (%) -37.40% P/E (TTM) 16.12 PB Ratio 1.40
Krebs Biochemicals & Industries Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Krebs Biochemicals & Industries Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 -7.89 Mar 2024 2.30 Mar 2023 -24.71 Mar 2022 -17.22 Mar 2021 -14.57
PARTICULARS Investing Activities Mar 2025 -4.97 Mar 2024 -7.82 Mar 2023 -12.64 Mar 2022 -22.90 Mar 2021 -22.55
PARTICULARS Financing Activities Mar 2025 12.86 Mar 2024 5.56 Mar 2023 37.34 Mar 2022 39.51 Mar 2021 37.66
PARTICULARS Net Cash Flow Mar 2025 0.00 Mar 2024 0.05 Mar 2023 -0.01 Mar 2022 -0.61 Mar 2021 0.54
Krebs Biochemicals & Industries Ltd Shareholding Pattern
This shows the ownership breakdown of Krebs Biochemicals & Industries Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 72.74%
Public 26.76%
Other Institutions 0.0%
FII 0.5%
Mutual Funds N/A%
About Krebs Biochemicals & Industries Ltd
Krebs Biochemicals & Industries Limited was initially incorporated as 'Krebs Biochemicals Limited' in 1991. The name of the Company was changed from Krebs Biochemicals Limited to Krebs Biochemicals & Industries Limited effected from November 21, 2003. Promoted by R T Ravi, Company engages in manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same.The Company develops commercially viable biotech processes for application in medicine, agriculture and industry. Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies.KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process. The Company commissioned 2.5 MW Co-generation Power Plant at Unit II in Vizag during 2003-04 and started operations on it from July, 2004 onwards.Production of two new products has commenced in the Nellore unit of the company during 2008. The sales from Unit II showed a healthy increase and small activity started in Unit I through Contract Manufacturing in 2010-11. The steep drop in income was attributed to discontinuing of Lovastatin manufacturing from April, 2012 in Unit ll. Starting from April 2012, the power supply was restricted the Andhra Pradesh government making it unviable and impractical to run the manufacturing of Lovastatin. Further, this affected the manufacturing of Simvastatin for which Lovastatin as the key raw material. Unit 2 due to the power shortage became sick in 2012. The Company undertook a financial restructuring to revive the operations in 2013. Ipca Laboratories Limited acquired 31.38% stake in the Company, making it an associate Company during FY15. During the year 2015-16, complete repairs and maintenance of both plants were undertaken to make plants ready for operations after the long shutdown. Some modernisation works were undertaken to meet the latest pollution control norms and safety regulations. All relevant licences were renewed. All the pending statutory requirements were addressed. Products range for both plants was established. Scale up operations including technology sourcing/development, pilot plant trials and validation trails for the identified products began in 2016.During the FY 2019-20, A total of four products were produced in its plant including Phenylephrine HCl, Simvastatin, Serratiopeptidase and RSS. The Vizag manufacturing facility of the Company started manufacturing few drug intermediates in 2023. The manufacturing operations at the Company's Vizag manufacturing unit remained closed since 9th February 2025 pursuant to order issued by Andhra Pradesh Pollution Control Board.
Independent Director
G V L Prasad
Registered office Kothapalli(V) Kasimkota(M), Anakapalli, Vishakapatnam, Andhra Pradesh, 531031
FAX :91-040-6680 8040
Background
Incorporation Year 1991
Face Value ₹10.00
Market Lot 1
FAQs on Krebs Biochemicals & Industries Ltd
How to buy Krebs Biochemicals & Industries Ltd shares on NSE?
To buy Krebs Biochemicals & Industries Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Krebs Biochemicals & Industries Ltd share price today?
The Krebs Biochemicals & Industries Ltd share price on NSE is ₹57.00 today.
What is the market cap of Krebs Biochemicals & Industries Ltd on NSE?
The company has a market capitalization of ₹122.90.
What is the PE & PB ratio of Krebs Biochemicals & Industries Ltd?
PE is -5 and PB is -0.846.
What is the 52 Week High and Low of Krebs Biochemicals & Industries Ltd shares?
Krebs Biochemicals & Industries Ltd stock price high: ₹113.90 Krebs Biochemicals & Industries Ltd stock price low: ₹51.